MENU

CERS Stock Tickeron detected bullish Stock Pattern: Triangle Symmetrical Top CERS on May 01, 2025, netting in a 5.88% gain over 1 month

A.I.dvisor
at Tickeron.com
Loading...
+5.88% Gain from a Successful pattern Triangle Symmetrical Top
CERS - Cerus Corp
Tickeron
Ticker: CERS
Company: Cerus
Gain: +5.88%
Confirmed: 05/01/25
Succeeded: 06/03/25
Total length: 35 days
On April 29, 2025, A.I.dvisor detected a Triangle Symmetrical Top Pattern (Bullish) for Cerus Corp (CERS, $1.36). On May 01, 2025, A.I.dvisor confirmed the Bullish pattern, setting a target price of $1.47. 33 days later, on June 03, 2025, CERS reached the target price resulting in a for traders who took a long position in the stock.

CERS's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for CERS turned positive on June 02, 2025. Looking at past instances where CERS's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 03, 2025. You may want to consider a long position or call options on CERS as a result. In of 110 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

CERS moved above its 50-day moving average on June 03, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CERS advanced for three days, in of 236 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

CERS broke above its upper Bollinger Band on June 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for CERS entered a downward trend on June 02, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.196) is normal, around the industry mean (24.191). P/E Ratio (0.000) is within average values for comparable stocks, (79.080). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (2.075) is also within normal values, averaging (42.393).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CERS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CERS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
CERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of the INTERCEPT Blood System for platelets and plasma

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
1220 Concord Avenue
Phone
+1 925 288-6000
Employees
288
Web
https://www.cerus.com